PMSF Innovation Award (Early Career Investigator)

_NOTE: Early submissions of letters of intent prior to March 1st are highly encouraged._

We are seeking highly novel grant applications which explore an understudied area of Phelan-McDermid syndrome research. Successful proposals will open new avenues of research in the field. Applications with clinical relevance will be preferred. Applications can be focused on any topic, but areas of special interest to families include: research across other neurodevelopmental disorders, development of tools for monitoring or managing symptoms, peripheral nervous system studies, identification of new drug candidates, implication of new cell types, and understanding of genes aside from SHANK3.

Eligibility

_You can learn more about this opportunity by visiting the funder's website._

• Must be an early career investigator (less than 8 years since completion of last degree).
• Applicant must hold a full-time position at a university/institution or an organization with 501c3 status.
• Applicants must have an MD, PhD, or MD/PhD. Applicants with a master's degree in life sciences are also eligible only if they are in a full-time professor position.
• Applicant must be the sole PI on the application, no Co-PIs are allowed.
  • A Co-PI is someone who would share the responsibility of the application equally.
• Applicant must have a mentor, who will write a letter of support and send in their CV/biosketch as part of the application.
• Co-Investigators are allowed.
  • Co-Investigators are not required and should only be included if specific expertise/resources are needed that are not possessed by the applicant or mentor.
  • Mentors cannot serve asCo-Investigators.
  • Applications without co-Investigators will not be at a disadvantage.
• International applicants welcome to apply.

Ineligibility

• Applicant and/or any team member of applicant cannot be involved in more than one PMSF grant application type per year.
• No portion of these funds shall be used to cover indirect institution costs.